{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T21:46:02Z","timestamp":1775943962929,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41575-025-01150-z","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:41:56Z","timestamp":1762947716000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The future of treating pancreatic exocrine insufficiency"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-198X","authenticated-orcid":false,"given":"J.-Matthias","family":"L\u00f6hr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6496-295X","authenticated-orcid":false,"given":"Miroslav","family":"Vujasinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ueg2.12674","volume":"13","author":"JE Dominguez-Mu\u00f1oz","year":"2025","unstructured":"Dominguez-Mu\u00f1oz, J. E. et al. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations. United Eur. Gastroenterol. J. 13, 125\u2013172 (2025).","journal-title":"United Eur. Gastroenterol. J."},{"key":"1150_CR2","unstructured":"Kuhlmann, H. The Magic Potions in the Belly Gland. The Story of Research into the Exocrine Pancreas and the Active Substance Pancreatin (Solvay Pharmaceuticals, 2000)."},{"key":"1150_CR3","doi-asserted-by":"crossref","unstructured":"Gonzalez, J.-P. & Macgregor-Skinner, G. in Zoonoses: Infections Affecting Humans and Animals (ed. Sing, A.) 1563\u20131611 (Springer, 2023).","DOI":"10.1007\/978-3-031-27164-9_41"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.3390\/ani13203281","volume":"13","author":"A Augustyniak","year":"2023","unstructured":"Augustyniak, A. & Pomorska-M\u00f3l, M. An update in knowledge of pigs as the source of zoonotic pathogens. Animals 13, 3281 (2023).","journal-title":"Animals"},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"113790","DOI":"10.1016\/j.jviromet.2019.113790","volume":"276","author":"P Modesto","year":"2020","unstructured":"Modesto, P. et al. Evaluation of a molecular method for hepatitis E virus (HEV) detection in pancreatin of porcine origin. J. Virol. Methods 276, 113790 (2020).","journal-title":"J. Virol. Methods"},{"key":"1150_CR6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1136\/gutjnl-2023-330602","volume":"73","author":"CS Thornton","year":"2024","unstructured":"Thornton, C. S. et al. Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients. Gut 73, 1702\u20131711 (2024).","journal-title":"Gut"},{"key":"1150_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/gutjnl-2024-332744","volume":"74","author":"N Kamar","year":"2025","unstructured":"Kamar, N. et al. Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E virus transmission? Gut 74, 331\u2013332 (2025).","journal-title":"Gut"},{"key":"1150_CR8","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.1016\/S1569-1993(24)01452-8","volume":"23","author":"M Sathe","year":"2024","unstructured":"Sathe, M., Freedman, S., Gallotto, R., Clarkin, M. & Borowitz, D. 614 Safety of ANG003, a non-porcine pancreatic enzyme replacement therapy in a phase 1 study. J. Cyst. Fibros. 23, S341 (2024).","journal-title":"J. Cyst. Fibros."},{"key":"1150_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/MEG.0000000000000720","volume":"28","author":"A Brock","year":"2016","unstructured":"Brock, A. et al. Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency. Eur. J. Gastroenterol. Hepatol. 28, 1305\u20131312 (2016).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jcf.2011.07.001","volume":"10","author":"D Borowitz","year":"2011","unstructured":"Borowitz, D. et al. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. J. Cyst. Fibros. 10, 443\u2013452 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"1150_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/17435390.2025.2544587","volume":"19","author":"H Saygin","year":"2025","unstructured":"Saygin, H. et al. Understanding the PET micro\/nanoplastics as an environmental stressor on pancreatin enzyme: leaching and binding characterization by multi-spectroscopic and molecular docking examination, and the resulting impact on Escherichia coli. Nanotoxicology 19, 508\u2013527 (2025).","journal-title":"Nanotoxicology"},{"key":"1150_CR12","doi-asserted-by":"publisher","unstructured":"Mierzejewski, K. et al. PET microplastics increase the risk of insulin resistance and pancreatitis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.10.25.620380 (2024).","DOI":"10.1101\/2024.10.25.620380"},{"key":"1150_CR13","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.hpb.2019.03.317","volume":"21","author":"L Lebreton","year":"2019","unstructured":"Lebreton, L., Smith, G., Jais, P., Schue, M. & Spoor, T. Reporting a phase II, open-label study assessing the safety and efficacy of MS1819-SD, a recombinant lipase, for the treatment of exocrine pancreatic insufficiency. HPB 21, S173\u2013S174 (2019).","journal-title":"HPB"},{"key":"1150_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpeds.2016.05.049","volume":"176","author":"JE Heubi","year":"2016","unstructured":"Heubi, J. E. et al. Safety and efficacy of a novel microbial lipase in patients with exocrine pancreatic insufficiency due to cystic fibrosis: a randomized controlled clinical trial. J. Pediatr. 176, 156\u2013161.e1 (2016).","journal-title":"J. Pediatr."},{"key":"1150_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2025.07.008","author":"M Sathe","year":"2025","unstructured":"Sathe, M. et al. Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2025.07.008 (2025).","journal-title":"J. Cyst. Fibros."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01150-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:02:18Z","timestamp":1766581338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01150-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1038\/s41575-025-01150-z","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.-M.L. and M.V. declare lecture honoraria from Abbott, Frostpharma, Nordmark and Viatris.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}